Rep. Diana DeGette (D-Colo.) recalls an unnerving visit to an old Centers for Disease Control and Prevention lab in Ft. Collins years ago—she observed modular storage units containing West Nile virus samples sitting behind the building, grass growing up into them, and insects flying around.
It’s the kind of mishandling she and other members of a House subcommittee have seen over and over again. Following another critical report issued last week, the Energy and Science Oversight and Investigations Subcommittee looked into continued problems with the program that regulates the use and transfer of dangerous pathogens and toxins.
Slipups at labs that conduct research on biological “select agents” and toxins continue, the General Accountability Office said in its report, including FEMA’s repeated receipt of toxic ricin at a training center, DOD’s shipment of live anthrax to scores of labs around the world, and NIH’s discovery of smallpox vials in an FDA storage room.
“I’ve been on this subcommittee and active in these investigations for over 15 years, and it’s just clear that things have been slipping through,” DeGette, the committee’s ranking member, told reporters following a Nov. 2 hearing.
“We’ve been really fortunate that we haven’t had any serious public health emergencies as a result of these errors but we could have,” she added.
The two agencies that run the Federal Select Agent Program—Agriculture’s Animal and Plant Health Inspection Service and Health and Human Service’s CDC—need to make sure they are sufficiently independent from the labs they inspect, the report says. In many instances, the fox guards the henhouse, with APHIS and CDC inspecting their own agencies’ facilities, raising conflict of interest concerns.
They also need to focus on lab activities posing the greatest risk of accidental exposure and develop a workforce plan to address employee retention and expertise concerns, according to the report.
“There will never be zero risk, unfortunately,” said Mary Denigan-Macauley, acting director of the GAO’s health care division, “but we do believe strongly that the oversight needs to be strengthened to prevent these safety lapses from happening.”
Read my story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)